Navigation Links
Delcath Names Harold C. Mapes as Executive Vice President of Global Operations
Date:5/3/2011

NEW YORK, May 3, 2011 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) today announced the appointment of Harold C. Mapes to the newly created position of Executive Vice President, Global Operations.  In this role, Mr. Mapes will lead the Delcath manufacturing and operations team, and will implement logistics and supply chain management in support of the Company's commercial launch in Europe later this year. Mr. Mapes will report directly to Eamonn P. Hobbs, CEO & President.

"With CE Mark approval for the Hepatic CHEMOSAT™ Delivery System now in hand, our next step is to scale up our operational and manufacturing capabilities to support the launch of the product in the European Union," said Mr.  Hobbs. "Harold is an excellent choice to lead this effort. He brings 30 years' worth of experience in operations and has proven that he can deliver lean manufacturing practices to companies of any size. Most importantly to Delcath, he has led operations for device companies making the transition from early stage to fully commercial entities with $200M in annual revenue. We are delighted to welcome Harold to the Delcath team."

Prior to joining Delcath, Mr. Mapes, 51, was Senior Vice President of Operations at AngioDynamics, Inc., where he was responsible for global sourcing, inventory, engineering, production, distribution and operations across four sites employing 300 workers. In his 18 years at AngioDynamics, he also held the positions of Vice President Operations, Director of Operations and Manufacturing Engineering, and Product Development Project Manager. In those roles, he coordinated the strategic corporate planning function, reduced manufacturing costs through implementation of lean manufacturing methods, and improved production performance by focusing on continuous improvement and compliance. Mr. Mapes has also held leadership positions in Oper
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 3, 2015 Report Details ... Drugs, Industry Changes and Emerging Opportunities What,s the ... Visiongain,s new study forecasts those pharmaceutical revenues. There ... industry. You also explore trends, results, treatments, R&D, ... gives revenue predictions to 2025 at overall world ...
(Date:9/3/2015)... , Sept. 3,  2015 About Vision ... care products considered for this report are Rx ... These products are primarily used by consumer for ... as Rx lenses and contact lenses require a ... readers are cosmetic products that can be purchased ...
(Date:9/3/2015)... , Sept. 3, 2015 This Defibrillators ... to save millions of lives across globe. This report ... Kingdom of Saudi Arabia . Stakeholders for ... suppliers, government agencies and regulatory bodies. The ... from two perspectives: by products and by end users. ...
Breaking Medicine Technology:Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Vision Care Market in the US 2015-2019 2Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm ... it has acquired a majority interest in Salter Labs ... a leading manufacturer of disposable respiratory and sleep diagnostics ... care markets.   "Salter represents an exciting ...
... Talecris Biotherapeutics (Nasdaq: TLCR ) announced ... Inhibitor [Human])(A1PI), a more concentrated and purified formulation of ... Canada for more than 20 years.  PROLASTIN-C delivers twice ... infusion volume and time in half when given at ...
Cached Medicine Technology:RoundTable Healthcare Partners Acquires Majority Stake in Salter Labs 2RoundTable Healthcare Partners Acquires Majority Stake in Salter Labs 3Talecris Biotherapeutics Launches PROLASTIN®-C in Canada 2Talecris Biotherapeutics Launches PROLASTIN®-C in Canada 3Talecris Biotherapeutics Launches PROLASTIN®-C in Canada 4Talecris Biotherapeutics Launches PROLASTIN®-C in Canada 5
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way ... , The patent-pending K Med Cups provide a quick and simple way to brew a ... cold, flu or cough. As a result, they enhance comfort and health. The invention features ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is ... 9 nationwide by Doximity. Faculty, residents and staff are honored to have contributed ... the quality of our ophthalmology residency program. Our faculty places a high priority on ...
(Date:9/4/2015)... ... September 04, 2015 , ... Having access to a doctor can ... an increasing amount of unnecessary emergency room visits which affects hospitals’ abilities to provide ... health bill. Fortunately, a solution to alleviate this problem has recently presented itself, the ...
(Date:9/4/2015)... ... September 04, 2015 , ... Lalonde Gordon ran a ... followed up with victory in the men’s 400 meters final, with an impressive 44.89 ... Field Championships in San Jose, Costa Rica in August 2015. The 44.64 time is ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers deal ... under the Stark physician self-referral law. “Stark Law DOs and DON’Ts: Best ... Information Services, Inc. (AIS), will detail which deals are attracting the most government ...
Breaking Medicine News(10 mins):Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... WASHINGTON, May 21 Regency Nursing and Rehabilitation Centers ... $4 million to settle allegations that Regency submitted false ... Justice Department and the U.S. Attorney,s Office for the ... Texas-based chain currently owns and operates 24 nursing home ...
... This year 28 students in 17 states have won awards ... Centers for Disease Control and Prevention and the DEET Education ... sixth-grade students to create posters that encourage children and adults ... they can cause. Downloadable files of the winning posters are ...
... Medicine Provider Times Implementation to Take Advantage of Government ... Allscripts announced today that Coordinated Health, the premier ... Valley, has selected the Allscripts Enterprise(TM) ... Practice Management (PM) solutions to connect and ...
... hundred physical therapists, physical therapist assistants, and students ... to educate lawmakers about the critical need for ... services. The group -- members of the American ... visits with Representatives and Senators. During their ...
... Offers Advice to Health PlansSEATTLE, May 21 May is ... mental health issues and getting support to those who need ... as they prepare to implement mental health parity requirements. ... and suggests ways to use this legislation as an opportunity ...
... blood glucose levels, study suggests , , THURSDAY, May 21 ... triglyceride fats are at increased risk of developing a ... of nerves that results in numbness, tingling and pain ... , A study by U.S. researchers indicates that ...
Cached Medicine News:Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 2Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 3Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 2Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 3Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 4Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 5Health News:Physical Therapists Advocate for Access to Rehabilitative Services on Capitol Hill 2Health News:Milliman Analysis: Preparing for Mental Health Parity 2Health News:High Blood Fats Tied to Diabetic Nerve Loss 2
... The PRO6000 power supply ... Thermo's power supply product offering. ... proteomic and genomic electrophoresis. This ... to proteomic applications such as ...
Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus....
... 200: 200V, .01-2A. 300: 300V, 4-400mA. 300 ... Select constant voltage or constant current mode. ... - Compact, lightweight and stackable. - Designed ... Ideal for DNA, RNA and protein electrophoreses ...
Handy 100V Power Supply is Low-cost, compact and lightweight. Easy to operate - either 50 or 100 VDC is selectable as the output voltage. These voltages are sufficient for ordinary electrophoresis....
Medicine Products: